{"References": [{"title": "Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations", "authors": "Lewis DA, Moghaddam B", "journal": "Archives of Neurology", "year": "2006", "volumes": "63", "first page": "1372", "last page": "1376", "DOI": "10.1001/archneur.63.10.1372"}, {"title": "Glutamate and dopamine in schizophrenia: an update for the 21st century", "authors": "Howes OD, Kapur S", "journal": "Journal of Psychopharmacology", "year": "2009", "volumes": "23", "first page": "120", "last page": "132", "DOI": "10.1177/0269881108096519"}, {"title": "NMDA receptor hypofunction model of schizophrenia", "authors": "Javitt DC, Zukin SR", "journal": "Journal of Psychiatric Research", "year": "1991", "volumes": "25", "first page": "219", "last page": "229", "DOI": "10.1016/0022-3956(91)90026-N"}, {"title": "Mismatch negativity in schizophrenia: a meta-analysis", "authors": "Umbricht D, Krljes S", "journal": "Schizophrenia Research", "year": "2005", "volumes": "76", "first page": "1", "last page": "23", "DOI": "10.1016/j.schres.2004.12.002"}, {"title": "Cognitive impairment in schizophrenia: a review of developmental and genetic models, and pro-cognitive profile of the alpha7 nicotinic acetylcholine receptor agonist DMXBA (GTS-21)", "authors": "Martin LF, Freedman R", "journal": "Biochemical Pharmacology", "year": "2007", "volumes": "74", "first page": "1192", "last page": "1201", "DOI": "10.1016/j.bcp.2007.07.011"}, {"title": "The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue", "authors": "Brisch R, Saniotis A, Wolf R, Bielau H, Bernstein HG, Steiner J, Bogerts B, Braun K, Jankowski Z, Kumaratilake J, Henneberg M, Gos T", "journal": "Frontiers in Psychiatry", "year": "2014", "volumes": "5", "first page": "47", "last page": "", "DOI": "10.3389/fpsyt.2014.00047"}, {"title": "Cognitive deficits in schizophrenia: understanding the biological correlates and remediation strategies", "authors": "Keefe RS, Harvey PD", "journal": "Clinical Psychopharmacology and Neuroscience", "year": "2012", "volumes": "10", "first page": "1", "last page": "11", "DOI": "10.9758/cpn.2012.10.1.1"}, {"title": "The neurobiology of cognitive impairment in schizophrenia: a tale of two transmitters and the relevance of NMDA receptor hypofunction", "authors": "Kantrowitz JT, Javitt DC", "journal": "Biological Psychiatry", "year": "2010", "volumes": "68", "first page": "e1", "last page": "e2", "DOI": "10.1016/j.biopsych.2010.04.028"}, {"title": "Schizophrenia, dopamine and the striatum: from biology to symptoms", "authors": "Simpson EH, Kellendonk C, Kandel E", "journal": "Trends in Neurosciences", "year": "2010", "volumes": "33", "first page": "485", "last page": "492", "DOI": "10.1016/j.tins.2010.06.002"}, {"title": "Cognitive remediation therapy for schizophrenia: theory and practice", "authors": "Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P", "journal": "Neuropsychological Rehabilitation", "year": "2011", "volumes": "21", "first page": "1", "last page": "20", "DOI": "10.1080/09602011.2010.517188"}]}